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Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that affects 
cognition and memory. Recent advances have helped identify many clinical sub-types 
in AD. Mounting evidence point toward structural polymorphism among fibrillar ag-
gregates of amyloid-β (Aβ) to being responsible for the phenotypes and clinical mani-
festations. In the emerging paradigm of polymorphism and prion-like propagation of 
aggregates in AD, the role of low molecular weight soluble oligomers, which are long 
known to be the primary toxic agents, in effecting phenotypes remains inconspicu-
ous. In this study, we present the characterization of three soluble oligomers of Aβ42, 
namely 14LPOs, 16LPOs, and GM1Os with discreet biophysical and biochemical 
properties generated using lysophosphatidyl glycerols and GM1 gangliosides. The 
results indicate that the oligomers share some biophysical similarities but display 
distinctive differences with GM1Os. Unlike the other two, GM1Os were observed 
to be complexed with the lipid upon isolation. It also differs mainly in detection by 
conformation-sensitive dyes and conformation-specific antibodies, temperature and 
enzymatic stability, and in the ability to propagate morphologically-distinct fibrils. 
GM1Os also show distinguishable biochemical behavior with pronounced neuronal 
toxicity. Furthermore, all the oligomers induce cerebral amyloid angiopathy (CAA) 
and plaque burden in transgenic AD mice, which seems to be a consistent feature 
among all lipid-derived oligomers, but 16LPOs and GM1Os displayed significantly 
higher effect than the others. These results establish a correlation between molecular 
features of Aβ42 oligomers and their distinguishable effects in transgenic AD mice 
attuned by lipid characteristics, and therefore help bridge the knowledge gap in un-
derstanding how oligomer conformers could elicit AD phenotypes.
This is an open access article under the terms of the Creative Commons Attribution- NonCommercial License, which permits use, distribution and reproduction in any medium, 
provided the original work is properly cited and is not used for commercial purposes.
© 2021 Federation of American Societies for Experimental Biology
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1 |  INTRODUCTION
Alzheimer disease (AD) is a fatal neurodegenerative disorder 
characterized by a progressive and irreversible cognitive de-
cline and memory loss among the elderly. The AD brain is char-
acterized by two pathological hallmarks; intracellular tangles 
comprised of hyper-phosphorylated tau protein and extracellu-
lar plaques composed of amyloid-β (Aβ) peptide aggregates.1 
However, the levels of low molecular weight (LMW) oligomers 
of Aβ correlate better with cognitive decline.2-5 It has now been 
well established that LMW oligomers are the primary toxic 
species responsible for early neuronal dysfunction in AD.6-8 
Therefore, understanding how Aβ oligomers are generated and 
what their structural features are, is of significant interest that 
may hold the key to the development of therapeutics for AD.
The stochasticity involved in Aβ aggregation, especially 
during early stages, gives rise to multiple pathways of aggre-
gation and with a diverse range of aggregate sizes and confor-
mations.9 Because of this, conformational heterogeneity and 
structural polymorphism are commonly observed among Aβ 
aggregates.10-14 Perhaps a profound impact of this is that the 
aggregate polymorphism may direct correlate to the clinical 
phenotypes observed among AD patients.15-18 Aggregates 
with distinct conformations have been identified among both 
familial and idiopathic AD brains.18 Differences in the struc-
ture between Aβ fibrils propagated with endogenous seed de-
rived from rapid-onset (rAD) and sporadic AD brains have 
reinforced the idea that conformational strains are in part re-
sponsible for different phenotypes observed.19 Therefore, un-
derstanding the relationship between aggregate conformation 
and their pathological function, along with the mechanisms 
underlying strain generation and propagation, has become 
imperative in deciphering AD pathogenesis.
Aβ aggregation is sensitive to the environmental conditions 
and interactions with other biomolecules.20-22 Being a part of 
the transmembrane domain of the amyloid precursor protein 
(APP), Aβ is influenced by membrane lipids during the early 
stages of Aβ aggregation.23-27 Lipid-associated Aβ has also 
been observed among AD patients. For instance, a novel mem-
brane-bound Aβ species was isolated from postmortem AD 
brains that were thought to trigger early stages of disease pa-
thology.28,29 Aβ was also observed to be tightly bound to GM1 
gangliosides, one of the most abundant gangliosides in the brain 
and constitutes a prime component of lipid rafts.30 It was later 
determined that GM1 binds Aβ with micromolar (μM) affin-
ity31,32 and induces a β-sheet secondary structure transition.33-36 
Aβ also binds and undergoes a structural transition to β-sheet 
in the presence of negatively charged lipid bilayer vesicles 
(liposomes).37-39 Similarly, micelles made up of spherical 
monolayers have also been shown to stimulate Aβ aggregate 
formation.40,41 Work from our lab has shown that distinct oligo-
mers of Aβ are generated in the presence of anionic micelles 
composed of fatty acids. These oligomers, termed large-fatty 
acid-derived oligomers (LFAOs) show many interesting bio-
physical and biochemical properties.9,22,42-45 LFAOs undergo 
faithful propagation to fibrils containing repeating oligomer 
assemblies in vitro,9 and a bilateral injection of these oligomers 
into neonatal CRND8 transgenic AD mice selectively induced 
Aβ deposition within the cerebral vasculature, leading to a con-
dition known as cerebral amyloid angiopathy (CAA).45 This led 
us to hypothesize that the faithful propagation of biophysically 
distinguishable Aβ oligomers toward structurally distinct fibrils 
may underpin the mechanisms governing clinical manifesta-
tions in AD. In this report, we sought to investigate the effect of 
micelle-forming anionic phospholipids on the biophyscial and 
biochemical characteristics of oligomers specifically using two 
anionic lysophosphatidyl glycerols (LPGs) with varying acyl 
chain lengths and a neutral sphingolipid, GM1 ganglioside. 
LPGs are good models of micellar phospholipids, while GM1 
gangliosides are a major component of membrane lipids and 
lipid rafts. We show that the LPG-derived oligomers, 14LPOs 
and 16LPOs, share many biophysical properties with LFAOs, 
while GM1-derived oligomers, GM1Os show some com-
monality but are more biophysically distinctive than the other 
oligomers. They also induce higher degrees of cytotoxicity and 
exacerbation of amyloid pathology in CRND8 mice brains. 
In addition, GM1Os and 16LPOs also induce highest level of 
CAA phenotype among the oligomers. These results bring to 
light how the physiochemical nature of micellar lipids can be 
tuned to induce biophysically distinguishable oligomers and 
how such properties correlate with their effect in mice brains. 
These results also refocus our attention toward unifying and dif-
ferential characteristics of lipid-derived oligomers to potentiate 
as “strains” in inducing specific phenotypes in AD.
2 |  MATERIALS AND METHODS
2.1 | Materials
Lyophilized stocks of synthetic Aβ42 WT were pur-
chased from the Yale School of Medicine (New Haven, 
1445151 and NRT 1449999; National 
Center for Research Resources, Grant/
Award Number: 5P20RR01647-11; 
National Institute of General Medical 
Sciences, Grant/Award Number: 8 P20 
GM103476-11
K E Y W O R D S
amyloid-β, Alzheimer disease, cerebral amyloid angiopathy, membrane lipids, oligomers, 
phenotypes
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CT) and from Dr Chakraborty's lab at the University of 
Mississippi. The monoclonal antibody Ab5 was obtained 
from Levites lab at the University of Florida (Gainesville, 
FL). Size exclusion chromatography (SEC) columns 
(Superdex-75 HR 10/30) were purchased from GE Life 
Sciences (Marlborough, MA). LPG (C14:0 and C16:0) 
and GM1 lipids were purchased from Avanti Polar Lipids, 
Inc (Alabaster, AL) while C12:0 NEFA was purchased 
from NuCheck Prep, Inc (Elysian, MN). Tris base, Tris 
hydrochloride, and sodium dodecyl sulfate (SDS) were 
purchased from Sigma-Aldrich (St. Louis, MO). Other 
routinely used chemicals, reagents, and consumables were 
purchased from either VWR, Inc (Radnor, PA) or Thermo 
Fisher Scientific, Inc (Waltham, MA).
2.2 | Purification of Aβ monomers
Synthetic Aβ (0.5-2  mg of lyophilized peptide) was dis-
solved in 490 μL of nanopure H2O (npH2O) and allowed to 
stand at 25°C for 0.5-1 hours. Ten minutes before loading 
onto a Superdex-75 HR 10/30 SEC column attached either to 
an AKTA FPLC system (GE Healthcare, Buckinghamshire) 
or a BioLogic DuoFlowTM system (Bio-Rad), NaOH was 
added to a final concentration of 10  mM. Monomer was 
then purified by loading the sample onto a pre-equilibrated 
(20 mM Tris, pH 8.0) column and fractionating at a flow 
rate of 0.5 mL/min at 25°C. Fractions of 500 μL were col-
lected, and monomeric Aβ was found to elute in between 
23 and 27 fractions. Cary 50 UV–vis spectrometer (Agilent 
Technologies, Inc; Santa Clara, CA) was used to determine 
the molar concentration of Aβ in each fraction using Beer-
Lambert's law (ε = 1450 cm−1 M−1 at 276 nm correspond-
ing to the single tyrosine residue). Matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry 
(MALDI-Tof) was used to confirm the purity and integrity 
of the peptide. The purified monomers were stored at 4°C 
in siliconized Eppendorf tubes to minimize protein reten-
tion on the tubes and used to initiate experiments within 
48 hours of purification.
2.3 | Purification of Aβ oligomers
Purification of Aβ oligomers was initiated by incubating 
freshly purified Aβ monomer (50  μM) with the speci-
fied lipid species in the conditions listed below. LFAOs, 
5 mM C12:0 NEFA; 14LPO, 0.4 mM C14:0 LPG; 16 LPO, 
0.15 mM C16:0 LPG; GM1O, 75 μM GM1. Additionally, 
50  mM NaCl and 0.01% NaN3 were added to all reac-
tions prior to incubation at 37°C in quiescent conditions 
for 48 hours. The samples were then purified via SEC, as 
described above, after first pelleting the insoluble peptide 
by centrifugation at 18 000g for 20 minutes. Fractions of 
500 μL were collected, and Aβ oligomers were fraction-
ated in the 18-20 fractions. The molar concentration was 
determined by UV–vis spectroscopy, as described above. 
Samples were either stored at 4°C in siliconized Eppendorf 
tubes and used for experimentation within 72 hours or lyo-
philized and kept at −80°C for extended storage prior to 
experimentation.
2.4 | Lyophilization and resuspension of Aβ
For lyophilization, aliquots of either 1 or 5  μg were made 
and flash-frozen by plunging into liquid N2 for 30 seconds 
prior to freeze-drying overnight using a FreeZone TriadTM 
freeze dry system (Labconco Corp.; Kansas City, MO) main-
tained at 0.420 mBar. Lyophilized samples were then stored 
at −80°C until use. To resuspend the lyophilized samples 
for experimentation, either nanopure H2O or Tris buffer (pH 
8.0) was added to reach the desired molar concentration of 
peptide, and the sample was allowed to stand at 4°C for at 
least 1 hour prior to centrifugation at 18 000 g for 20 min-
utes. The supernatant was then carefully removed and used 
for experiments.
2.5 | Generation of Aβ fibrils
Aβ monomer (100-150  μM) was added to 150  mM NaCl 
and allowed to incubate at 37°C in quiescent conditions for 
4-5  days for Fon generation. After incubation, the sample 
was subjected to centrifugation at 18 000 g for 20 minutes 
before carefully discarding the supernatant and resuspending 
the pellet in fresh 20 mM Tris (pH 8.0) with 0.01% NaN3. 
ThT fluorescence and centrifugation were used to determine 
percentage conversion to Aβ fibrils, which was typically 
80%-90%. Fibrils were stored at 4°C and used within 30 days.
2.6 | Oligomer seeding reactions
Aβ monomer (25 μM) was seeded with 5 μM oligomer seeds 
in 20 mM Tris (pH 8.0) with 50 mM NaCl and 50 μM ThT. 
The reactions were kept in BioTek Synergy 96 well plate 
reader at 37°C and ThT fluorescence was monitored up to 
48 hours. All experiments were carried out by adding 200 µL 
of the reaction mixture in Corning 96-well plate (black). ThT 
fluorescence was recorded after an interval of every 10 min-
utes using excitation at 452 nm and emission at 485 nm at 
37°C, shaking samples for 1  second before each read. The 
kinetics data were processed by subtracting the blank buffer 
reading from the experimental data followed by normaliza-
tion using the OriginLab 8.0 program.
4 of 18 |   SAHA et Al.
2.7 | Partially denaturing and PAGE with 
immunoblotting
Samples were diluted into 1× Laemmli loading buffer with 
1% SDS and loaded without boiling, onto either 4%-12% 
NuPAGE or 4%-20% Bis-Tris Bio-Rad TGX gels. Pre-
stained molecular-weight markers (Novex Sharp Protein 
Standard, Life Technologies) were run in parallel for MW 
determination in denaturing PAGE. For immunoblotting, 
proteins were transferred onto a 0.2  μm nitrocellulose 
membrane (Bio-Rad). Following the transfer, the immu-
noblot was boiled for 1  minutes in a microwave oven in 
1× PBS, followed by blocking for 1.5 hours at 25°C in 1× 
PBS containing 5% nonfat dry milk with 1% Tween 20. 
Blots were then probed overnight at 4°C with a 1:6000 di-
lution of Ab5 monoclonal antibody, whose epitope is 1-16 
sequence of Aβ. Following primary incubation, blots were 
probed with a 1:6000 dilution of anti-mouse, horseradish 
peroxidase-conjugated secondary antibody for 1.5 hours at 
25°C before being imaged using a Super SignalTM West 
Pico Chemiluminescent Substrate kit (Thermo Fisher 
Scientific). Dot blots. Samples (225 ng in 5 µL) were spot-
ted onto a 0.2 µm nitrocellulose membrane and allowed to 
dry at room temperature for 1 hour. The blots were blocked 
for 1.5 hours with 1× PBS containing 5% nonfat dry milk 
and probed overnight at 4°C with 1∶2000 and 1:6000 di-
lutions of polyclonal conformational specific antibody OC 
(Millipore Inc) and A11, respectively, along with Ab5 mon-
oclonal antibody. Blots were then incubated with anti-rabbit 
(for OC and A11) or anti-mouse (for OC) horseradish per-
oxide (HRP) conjugated secondary antibody for 1.5 hours 
and developed with ECL reagent (Thermo Scientific).
2.8 | Curcumin and ANS fluorescence
Curcumin, and 8-anilino-napthalene-1-sulfonic acid 
(ANS) fluorescence were measured on a Cary Eclipse 
AQ6fluorometer (Agilent Technologies, Inc) in scan mode. 
Fluorescence spectra for curcumin were obtained by excit-
ing the sample at 430 nm, while scanning emission between 
470 and 600 nm upon the addition of buffered Aβ samples 
(5-7 μM) and curcumin (5 μM) in 25% EtOH. The slit widths 
for excitation and emission were kept constant at 10  nm. 
The data were normalized against the concentrations of the 
oligomers and averaged for three independent data sets. For 
ANS, Aβ samples (3  μM) were equilibrated for 2  minutes 
with ANS (100 μM) in 20 mM Tris pH 8.00 before measur-
ing the fluorescence using excitation at 388 nm and scanning 
emission between 400 and 650 nm. The integrated intensity 
was plotted against the wavelength for each sample was plot-
ted as bar-graphs and averaged for three independent data 
sets.
2.9 | Fourier transform infrared (FTIR) 
spectroscopy
Lyophilized Aβ samples were resuspended in D2O to a final 
concentration of 1  mM before accumulating spectra on a 
Nicolet 6700 instrument equipped with an ATR accessory. A 
total of 64 accumulations were collected by scanning 4000-
650 cm−1 at a resolution of 4 cm−1. Spectra were processed 
by blank subtraction (using D2O as the blank) and baseline 
correction using the OriginLab 8.0 program.
2.10 | Circular dichroism (CD) 
spectroscopy and thermal denaturation
Far UV CD spectra (260-190 nm) for the oligomers (5-8 µM) 
were collected on a Jasco (Easton, MD) J-815 spectropo-
larimeter using a 1 mm pathlength cuvette with an average 
of 6-16 spectral scans at a rate of 50 nm/min (8 seconds re-
sponse time, 1 nm bandwidth, 0.1 nm data pitch). Averaged 
spectra were smoothed using the Savitzky-Golay algorithm 
with a convolution width of 15 using the Jasco spectrum 
analysis program. Temperature stability analysis was per-
formed using SDS as a denaturant as described prior.46 
Briefly, SDS (1% wt/vol) was added to a solution of Aβ 
oligomers (1 μM) in a 1 cm pathlength cuvette, followed 
by heating from 10 to 90°C, while monitoring the signal at 
208 nm that corresponds to the emergence of an α-helical 
structure. In addition, the far-UV scans of pre- and post-
melt samples were measured. The data were processed by 
normalizing from 0 to 1, where 1 and 0 represent the fully 
melted and unmelted oligomers, respectively. The normal-
ized values of fully melted samples were calculated by cor-
relating the 90°C data with the post-melt scans wherein the 
maximum difference in ellipticity between 222 and 208 nm 
to be <0.1 was considered to be 100% helix based on estab-
lished observations on SDS-protein systems.47-49 The data 
obtained was fit using the Boltzman function in OriginLab 
8.0 program to derive Tm values.
Thermodynamic deconvolution of the data was performed 
as follows: The equilibrium constant K at a given temperature 
is expressed as:
where N and D represent native and denatured oligomers, 
respectively. The change in.
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where θ is the ellipticity at λ208 and K is expressed as,
As we know,
From this, we can deduce,
From this equation, linear vant Hoff's plots were gener-
ated from which ΔH and ΔS were calculated from the slope 
and y-intercept, respectively.
2.11 | Dynamic light scattering (DLS)
DLS was collected by averaging 12 runs of 10 seconds each 
with a pre-equilibration time of 30 seconds using a Zetasizer 
Nano S instrument (Malvern, Inc, Worcestershire, UK) with 
70 µL volume and 1 cm cuvette pathlength. The diameter was 
determined using the volume (%) function.
2.12 | Electrospray ionization mass 
spectrometry (ESI-MS)
All samples were evaporated to dryness using vacuum evap-
oration followed by resuspension at a concentration of 10 μM 
in a H2O:CH3CN:HCOOH (1:1:0.2) solvent. Samples were 
analyzed by direct infusion into a FinniganTM LXQTM ion 
trap mass spectrometer (Thermo Fisher Scientific) operated 
in negative ion mode. Signals were accumulated by scan-
ning the spectrum from 150 to 2000 m/z for a total of 3 min-
utes (~800 total scans) at a constant flow rate of 100 μL/
min. Other instrument parameters were kept as follows: spray 
voltage (5 kV), capillary temperature (275°C), capillary volt-
age (−42 V), and automatic gain control (1.5 × 104).
2.13 | Analytical ultracentrifugation
Sample Preparation A 4 mM stock solution of HiLyte 647 
in 50% DMSO was diluted to 160  μM aliquot, which was 
incubated with 10  μM isolated oligomer (14LPO, 16LPO, 
LFAO & GM1O) in 10 mM sodium phosphate buffer at pH 
8, and was incubated overnight at 4°C kept with constant 
orbital shaking at 80 rpm. The free dye was removed from 
the dye-protein mixture using 7  kDa Zeba Spin desalting 
columns in 10 mM sodium phosphate buffer at pH 8 (Thermo 
Scientific) by centrifuging samples at 900 g at 4°C for 1 min-
utes. The dye and protein absorbance were measured using 
a Cary 50 UV–vis spectrometer (Agilent Technologies, Inc; 
Santa Clara, CA) to determine the amount of dye bound 
to protein. Sedimentation velocity experiments were per-
formed in a Beckman XL-I centrifuge (Beckman Coulter, 
Inc, Indianapolis, IN) using absorbance and interference op-
tics by measuring intensity scans at 280 nm at the Physical 
Biochemistry Facility at Florida State University. The ex-
periments were performed at 20°C in two-channel Epon cen-
terpieces with an AN60 Ti rotor at 55, 000 rpm. A 10 mM 
sodium phosphate at pH 8.0 buffer was the used for protein 
solubilization. Data were processed and analyzed using the 
SedFit program50 to generate c(S) and MW distributions. The 
frictional coefficient (f/f0) value of 1.4 was used for data pro-
cessing and calculations. The partial specific volume at 20°C 
of the protein (0.7021 cm3 g−1) was used that was estimated 
from the peptide sequence.
2.14 | Proteinase K (PK) digestion
A 20 mg/mL of PK stock solution from Ambion was diluted 
to 57  ng/mL in 20  mM Tris pH 8.0 to digest 451.5  ng of 
each oligomer sample (16LPO, 14LPO, GM1O, and LFAO) 
by shaking at 200 rpm at 37°C for 40, 30, 20, and 10 min-
utes, respectively. The reactions were quenched with 0.5 mM 
PMSF for 1  minute. Subsequently, ~337  ng of protein for 
each oligomer sample was run on 1% SDS PAGE gel and 
we transferred onto a 0.2 μm nitrocellulose membrane (Bio-
Rad) for immunoblotting. Immunoblots were probed with a 
1:6000 dilution of Ab5 monoclonal antibody & anti-mouse, 
horseradish peroxidase-conjugated secondary antibody, re-
spectively. The immunoblots were imaged using a Super 
Signal West Pico Chemiluminescent Substrate kit (Thermo 
Fisher Scientific). Oligomer band intensities in the gel were 
calculated by choosing a 6 mm2 area between molecular 
weight 50-80 kDa and subtracting the intensity of blank on 
a similar area of the gel with the help of Image Lab (Bio-
Rad) software. Intensity vs time plots were then plotted using 
OriginLab 8.0.
2.15 | Atomic force microscopy
Peptide oligomer and fibril samples were prepared following 
our previously published procedure.46 An acidic solution of 
3-aminopropyltriethoxysilane (500 µL of APTES in 50 mL of 
1 mM acetic acid) was prepared and 150 µL was deposited 
onto freshly cleaved mica. After 20 minutes, the solution was 
decanted from the surface and the substrate was washed three 
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then dried with a stream of N2 and set in a desiccator for an 
hour. AFM samples were then prepared by depositing 150 µL 
of oligomer or fibril solution (2 µM in 20 mM Tris-HCl, pH 
8.0). After 30 minutes, the solution was decanted and the sub-
strates were dried under a stream of N2. AFM samples were 
stored in the desiccator until imaging. Image analysis was 
conducted using a Dimension Icon Atomic Force Microscope 
(Bruker) in PeakForce Tapping mode equipped with an 
SNL-C cantilever (nom. tip radius of 2 nm; nom. resonance 
frequency of 56 kHz; nom. spring constant of 0.24 N/m) in a 
standard probe holder under ambient conditions. Images were 
acquired with 512 × 512 data point resolution in NanoScope 
v8.15 software and analyzed in NanoScope Analysis v1.50.
2.16 | NMR
The 1H NMR spectra were acquired on the Bruker Advance—
III-HD 850 MHz NMR spectrometer equipped with a Bruker 
TCI cryoprobe at the high field NMR facility of the University 
of Alabama, Birmingham. The spectra of the samples (10-
12 μM) in 10 mM phosphate buffer at pH 8.0 with 10% D2O 
were collected at 25°C with 6144 or 8192 scans with 14 ppm 
sweep width centered around water peak with a D1 delay of 
1.0  second. Excitation-sculpting water suppression (zgesgp) 
was used. The data were processed using Bruker TopSpin 3.5 
analysis software with standard methods with phase corrections.
2.17 | Cell viability XTT assay
SH-SY5Y human neuroblastoma cells (ATCC, Manassas, 
VA) were plated in a clear 96 well-plate at a density of ap-
proximately 20  000 cells/well in growth media containing 
1:1 mixture of DMEM/F12 medium with 10% fetal bovine 
serum and 1% Pen-Strep at 37°C in a humidified atmos-
phere of 5.5% CO2. After 24  hours, media was replaced 
with freshly prepared Aβ oligomers in siliconized tubes re-
suspended in growth media and incubated for 40 hours. Cell 
viability assay was performed using 2,3-bis(2-methoxy-4-
nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl] -2H- tetra-
zolium hydroxide (XTT) cell viability assay kit (Biotium). 
Absorbance was measured at 475 and 660 nm using Synergy 
HTX Multi-Mode Reader- BioTek Instruments.
2.18 | Tg CRND8 mice injections and 
immunohistochemistry
2.18.1 | Mice
All animal husbandry procedures performed were approved 
by the Institutional Animal Care and Use Committee. 
TgCRND8 were maintained as described before,51 transgenic 
males were crossed with B6C3F1 ntg females.
2.18.2 | Neonatal injections
TgCRND8 mice were injected with 2 μL of 10 μM isolated ol-
igomers (14LPOs, 16LPOs, LFAOs, and GM1Os) in 10 mM 
sodium phosphate buffer at pH 8.00, ICV into both hemi-
spheres using a 10 mL Hamilton syringe with a 30 g needle 
on day P0 as described before46,52 and aged till 2 months. Aβ 
levels from the Ripa, 2% SDS, and 70% FA-extracted sam-
ples were quantified using end-specific sandwich ELISA as 
previously described.53 Aβ40 was captured with mAb 13.1.1 
(human Aβ35-40 specific; TE Golde) and detected by HRP-
conjugated mAb 33.1.1 (human Aβ1-16; TE Golde). Aβ42 
was captured with mAb 2.1.3 (human Aβ35-42 specific; TE 
Golde) and detected by HRP-conjugated mAb 33.1.1 (human 
Aβ1-16; TE Golde). ELISA results were analyzed using 
SoftMax Pro software.
2.18.3 | Immunohistochemical imaging and 
image processing
Right hemibrain was fixed in 4% paraformaldehyde. 
Immunohistochemical staining was performed by biotinylated 
pan Aβ pan antibody mAb5 (1:1500, T. Golde). To detect we 
used biotinylated secondary antibody and ABC-horseradish 
peroxidase staining kits (Vector Laboratories, Burlingame, 
CA). After development by 3,3′-Diaminobenzidine (DAB) 
(Sigma-Aldrich) substrate and counterstaining with he-
matoxylin, the slides were coverslipped and images were 
scanned by Aperio XT System (Leica Biosystems, Buffalo 
Gove, IL, USA) and analyzed using either Aperio positive 
pixel count or ImageJ program. Brightness and contrast al-
terations were applied identically on captured images using 
Adobe Photoshop CS3.
2.18.4 | Quantification of Aβ deposition
Aβ plaque burden and intensity of astrogliosis staining were 
calculated using the Positive Pixel Count program (Aperio). 
At least three sections per sample, 30 μm apart, were aver-
aged by a blinded observer to calculate plaque burden. For 
CAA, three blinded observers reviewed the images and 
scored the extent of CAA based on the following criteria; 
“3” = more than 50% blood vessels have staining along the 
full circumference. “2” = 25%-50% of blood vessels have 
substantial staining. “1” = some blood vessels are stained 
with anti-pan Aβ biotinylated antibody. “0”—no staining ob-
served in blood vessels.
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3 |  RESULTS
3.1 | Lysophosphatidyl glycerol and GM1 
ganglioside micelles promote the formation of 
Aβ oligomers
Aβ oligomer formation was investigated in the presence 
of LPG micelles containing saturated 14 acyl carbon chain 
(C14:0 LPG) or 16 acyl carbon chain (C16:0 LPG) (Figure 1). 
Freshly purified Aβ monomer (50 μM) buffered in 20 mM 
Tris pH 8.0 and 50 mM NaCl was incubated with C14:0 or 
C16:0 LPG micelles and allowed to incubate at 37°C under 
quiescent conditions. The final concentration of LPG was 
kept at least two-fold above the reported critical micelle 
concentration (CMC) to ensure the lipids were in a micellar 
form.54 After 48 hours of incubation, aliquots of the reactions 
were electrophoresed under partial denaturing conditions and 
visualized via immunoblotting, which revealed the presence 
of 30-60 kDa oligomers formed in the presence of LPG mi-
celles along with some high molecular weight (HMW) bands 
(those that do not enter the gel) and monomers (Figure 1A). 
Immunoblot of the control reaction in the absence of LPG 
contains only a disperse oligomer band corresponding to 
~200 kDa and fibrils that failed to enter the gel, suggesting 
that LPGs induce the formation of low molecular weight 
(LMW) Aβ oligomers (Figure  1A, lane C). Incubations of 
Aβ monomers (50 μM) in the presence of GM1 gangliosides 
in similar buffer and temperature conditions show oligomer 
bands with a bimodal molecular-weight distribution centered 
at ~40 and ~56 kDa, respectively (Figure 1A; GM1). Unlike 
LPG incubated reactions, no HMW fibrils were observed in 
the immunoblot of GM1-derived oligomers.
Fractionation of LPO incubated samples on a Superdex-75 
column (Figure 1B-D) showed three Aβ species corresponding 
to monomers, oligomers, and fibrils similar to those observed 
in the immunoblots. Fractionation of the control sample in 
the absence of LPG or GM1 micelles (Figure 1B-D; dotted 
lines) showed only fibrils and monomers, further indicating 
that the oligomers are formed only in the presence of the lip-
ids. Similar fractionation of Aβ incubated with GM1 showed 
predominantly two fractions (Figure  1E). Immunoblots of 
the fractionated 14LPOs and 16LPOs revealed that the peak 
close to the void volume (fraction 17) contained fibrils, as 
expected (Figure 1B-C; inset). The fractions eluting in more 
inclusive volumes at 18-20 contained the soluble oligomers 
(Figure  1B-C; inset), while monomers eluted in fractions 
at the most included volume (fraction 25). Similarly, im-
munoblots of GM1Os (Figure  1D) showed fractions 18-20 
containing the oligomers (Figure  1D; inset), and notably, 
HMW aggregates in fraction 17 were absent (Figure  1D). 
Furthermore, the isolated oligomer samples electrophoresed 
under non-denaturing conditions (no heat; no SDS treatment) 
showed a differential migration pattern (based on m/z ratio) 
for GM1Os compared to other oligomers (Figure S1), which 
could suggest either the oligomer is different in size, charge 
or both, or the migration pattern is affected by the extent of 
lipid association in the oligomers.
Therefore, to investigate whether lipids are associated with 
isolated oligomers quantitatively, the samples were analyzed 
using electrospray ionization mass spectrometry (ESI-MS) in 
negative ion mode (Figure S2). Spectra of the controls, C14:0 
LPG, C16:0 LPG, and GM1 in the absence of Aβ showed the 
presence of the –1 ion for both C14:0 and C16:0 LPGs at 455 
and 483 m/z, respectively (Figure S2A,B). Multiple signals 
were observed with GM1 control (Figure S2C) corresponding 
to the varying sphingosine (denoted “d”) and acyl moieties 
present in the commercial sample. This primarily included 
the 1545 ([(d18:1, C18:0) – 1H]-1) and 1573 ([(d20:1, C18:0) 
– 1H]-1) m/z ions, which have been observed previously.55-57 
Also observed were the 1612 and 1680 m/z ions, which were 
unassigned derivatives of GM1, consistent with the presence 
of multiple GM1 isoforms based on the manufacturer's note 
(Avanti Polar Lipids). Control Aβ reactions either for mono-
mers or LFAOs yielded a 1503 m/z signal corresponding to 
the [M − 3H]3− Aβ ion (Figure  S2D-E). The [M − 3H]3− 
Aβ ion was also observed in the isolated 14LPO and 16LPO 
F I G U R E  1  A, SDS-PAGE -immunoblots of the samples of Aβ (50-60 µM in 20 mM Tris, 50 mM NaCl, pH 8.0 and 0.01% NaN3) incubated 
with C14:0 (400 µM), C16:0 (150 µM), and GM1 gangliosides (75 µM) lipid micelles above their critical micelle concentrations and imaged 
after 48 h of incubation. B-D, Fractionation of samples by SEC of the reactions in (A). The dotted lines are fractionation profiles of the control 
reaction in the absence of lipids. (insets; B-D) corresponding SDS-PAGE immunoblots of oligomeric fractions (denoted by the black line). Fraction 
numbers are labeled at the bottom of the gels
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samples but not the ones corresponding to the free C14:0 
LPG (455 m/z) and C16:0 LPG (483 m/z) lipids (Figure S2F-
G). This suggests that the isolated oligomers have an insig-
nificant amount of lipid association similar to LFAOs as 
observed previously.42 In contrast, isolated GM1Os showed 
the presence of GM1 gangliosides in the sample, and surpris-
ingly no Aβ signals were observed (Figure S2H), suggesting 
that the lipids were associated with the isolated GM1Os. It is 
unclear as to why Aβ signals were not observed on the spec-
trum but it could be due to disruption in ionization caused by 
GM1 association. The presence of GM1 in isolated GM1Os 
was then quantified by HPLC (Figure  S3), which revealed 
the presence of ~20% (molar) of GM1 lipid in the isolated 
GM1Os (2.5 μM in 12 μM oligomer sample).
3.2 | Biophysical 
characterization of oligomers
The size and secondary structure of micelle-derived oligom-
ers, LPO and GM1O samples were analyzed by dynamic 
light scattering (DLS), circular dichroism (CD), and Fourier 
transform infrared (FTIR) spectroscopies (Figure  2). DLS 
size analysis of 14LPO, 16LPO, and GM1O samples before 
F I G U R E  2  A-C, DLS size distribution profiles of oligomers weight by volume fractions from which hydrodynamic diameter (Dh) were 
determined. Shown are profiles for nine independent samples of 50-60 µM Aβ in 20 mM Tris, 50 mM NaCl at pH 8.0 and 0.01% NaN3 incubated 
with (A) C14:0 LPG (B) C16:0 LPG, and (C) GM1 ganglioside micelles above their respective CMCs in the same buffer for 48 h. D-F, DLS size 
distribution profiles for the isolated oligomers after SEC fractionation (six independent samples): (D) 14LPOs. E, 16LPOs and (F) GM1Os. G, Size 
distribution based on sedimentation velocity experiments. H, Far UV circular dichroism of 10-16 µM samples of 14LPOs, 16LPOs, LFAOs, and 
GM1Os after SEC fractionation. I, FTIR spectra for 14LPOs, 16 LPOs, and GM1Os after SEC isolation along with fibril and LFAO controls.
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SEC isolation revealed some degree of polydispersity with 
14LPOs, a significant extent with 16LPOs, and a minimal ex-
tent with GM1Os (Figure 2A-C). Both 14LPOs and GM1Os 
contained predominant species with ~10 nm diameter and to 
a lesser extent large species >0.5 μm. Moreover, 16LPOs 
showed three distinct species between 10  nm and 10  μm. 
Fractionation of the oligomers by SEC resulted in more 
monodisperse isolated fractions centered around 10 nm in di-
ameter (Figure 2D-F). Here too, 16LPOs showed variations 
in size between 5 and 10 nm between different preparations 
(Figure 2E). Unlike LPOs, both prior to and after SEC iso-
lation, GM1Os displayed monodispersity with DLS spectra 
centered at 10 nm (Figure 2C,F), again suggesting that fibril 
formation may be minimal in the presence of GM1. This in 
turn suggests the possibility that the association of GM1 to 
Aβ could lead to a pathway different from fibril formation. 
Overall, the data suggest that all three oligomers have largely 
similar hydrodynamic diameters that are in the same range 
as of LFAOs,42 which is consistent with the SEC and im-
munoblot data.
More stringent size estimates were performed by 
sedimentation velocity experiments. LFAOs showed a 
predominant species centered around 5S and a less abun-
dant one around 7S (Figure 2G) corresponding to 60 and 
110 kDa (12 and 24mers), respectively, which is consis-
tent with our previous observation.42 The 14LPOs and 
16LPOs showed a sedimentation coefficient peak spread 
between 5S and 8S (~60-120 kDa) corresponding to 13-
26mers (Figure  2G). The broad peak suggested hetero-
geneity especially in the 16LPO sample which the DLS 
data also indicates (Figure 2E). GM1Os showed relatively 
discrete peaks with a major species centered around 3S, 
along with minor ones at 6.5S and 9S that correspond to 
9mers, 18mers, and to a lesser extent, 30mers, respectively 
(Figure 2G). The secondary structure of the oligomers was 
investigated by both far-UV CD and FTIR spectroscopy 
(Figure  2H,I). All oligomers showed CD spectra with a 
minimum at 217 nm indicative of β-sheet secondary struc-
ture (Figure  2H). To ascertain the type of the β-sheets 
(parallel or anti-parallel), FTIR spectra spanning the am-
ide-I region was investigated (Figure 2I).58 FTIR spectra 
of control fibrils formed in the absence of lipids (dashed 
line) and LFAOs (dotted line) showed an absorbance max-
imum at 1625 cm−1, indicative of parallel β-sheets. Nearly 
identical spectra were observed for 14LPOs, 16LPOs, 
and GM1Os with a peak at 1620-1625 cm−1 (Figure 2I). 
Together with the absence of a peak at 1690  cm−1 indi-
cates a parallel β-sheet structure for the samples. While 
these results differ with some reports of Aβ oligomers 
containing anti-parallel β-sheets,59-61 they do parallel the 
observation for LFAOs,44 which brings to focus a unifying 
characteristic among lipid-derived oligomers.
3.3 | Lipid-derived oligomers have ring-
like morphology
Morphological features of the isolated oligomers were in-
vestigated by atomic force microscopy (AFM). All the oli-
gomers showed morphology resembling spherical, punctate 
dots (Figure 3A,E,I). The 14LPO samples showed largely a 
uniform size with height centered at 1.5 nm with a few larger 
ones with 3.5 nm (Figure 3C). The 16LPO samples displayed 
a mixture of different sizes ranging between 2, 2.5, and 5 nm 
(Figure 3G), which is consistent with the heterogeneity ob-
served in DLS (Figure 2E) and sedimentation velocity data 
(Figure  2G). GM1Os showed the most homogenous dis-
tribution of spherical particles with a height of 2.5-3.0 nm 
(Figure 3K), which is also consistent with DLS (Figure 2F). 
Sizes of these oligomers are slightly smaller than those ob-
served for LFAOs which were 5-6  nm in height.42,46 The 
phase images of the oligomers showed a presence of depres-
sion in the middle of the spherical dots, suggesting a ring- or a 
doughnut-shape for all the oligomers species (Figure 3B,F,J). 
The phase measurements were made as precise topographical 
analyses were limited by the large size of the AFM cantilever 
tip. The phase analysis describes the energy dissipation and 
how the tip interacts with the samples by detecting differences 
in the probe's oscillation in reference to the excitation oscilla-
tory signal, while maintaining a constant amplitude. Physical 
features that would cause the phase lag to include differences 
in surface stiffness, viscoelasticity, adhesion, or topographi-
cal variations,62 as we have shown previously.46,63,64 The data 
thus derived were further confirmed by the cross-sectional 
analysis of the oligomers (Figure 3D,H,L), which is similar 
to those observed for LFAOs.46
3.4 | Stability of Aβ oligomers
Thermodynamic stability of the oligomers was determined 
by assessing their ability to resist denaturation by detergent 
(1% SDS) as a function of temperature. Upon the addition of 
SDS to the oligomers (1 μM), the conformational change from 
β-sheet to α-helix was monitored as a function of increasing 
temperature (Figure 4A-F). Panels a-e in Figure 4 show far-
UV CD spectra for pre- and post-melted oligomers and fibrils 
at 10 and 90°C, respectively, which show this conformational 
transition. The melting profiles were generated by monitor-
ing the transition at λ208 nm, while sweeping the temperature 
from 10 to 90°C. Oligomers and fibrils show two-state melting 
profiles with a sigmoidal denaturation pattern (Figure 4F). Up 
to ~40°C, no changes in the ellipticity was observed for any 
of the oligomers (Figure 4F), displaying their ability to resist 
denaturation at physiological temperatures. However, some 
distinguishable differences were observed in the denaturation 
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pattern among oligomers and fibrils. First, all oligomers melted 
into different degrees of α-helical structures as determined by 
the difference between ellipticities at wavelengths 222 and 
208 nm. Although the debate on whether the relative intensity 
of ellipticity ([θ]) between λ222 and λ208 indicates the extent of 
α-helix or 310 helix seem to be unsettled,
65 it is clear that in the 
presence of SDS denaturant, helix displays a value of [θ]222 
– [θ]208 < 1.0.
47-49 This criterion was used in normalizing the 
data (see Methods). Based on this analysis, GM1Os displayed 
complete melting followed by 14LPOs, while LFAOs and 
16LPOs, which showed partial melting but to the same extent 
of the helix (Figure 4F). As expected, fibrils resisted melting 
to the largest extent with only ~25% of β-sheet melting into 
an α-helix (Figure 4F). Differences were also observed for the 
mid-point of transition corresponding to the melting tempera-
ture (Tm), defined as the temperature at which half of the pro-
tein is denatured ([N]/[D] = 0.5). From this analysis, GM1Os 
showed the lowest Tm with 60°C followed by 75, 69, and 70°C 
for 14LPOs, 16LPOs, and LFAOs, respectively. Further de-
convolution of the data showed that the denaturation transition 
is largely entropy-driven for GM1Os as compared to others im-
plicating the presence of exposed hydrophobic surfaces on the 
oligomers in part by the complexed lipid (Figure S3).
In parallel, the stability of oligomers toward enzymatic 
digestion was also probed by proteinase K (PK) treatment. 
The oligomers were incubated with (57 ng/mL) of PK and 
the stability was assessed based on the disappearance of 
the oligomer band from immunoblot as a function of time 
(Figure 4G,H). Each oligomer was incubated in small ali-
quots with PK in the buffer for 10, 20, 30, and 40 minutes 
and was subjected to electrophoresis on partially denatur-
ing SDS-PAGE followed by western blotting with mono-
clonal antibody Ab5. With all oligomers, an immediate 
decrease in the band intensity and molecular weight was 
observed within 10 minutes of incubation as compared to 
the control (C) (Figure 4G). In addition to the reduction in 
oligomer band intensity, all oligomers except LFAO con-
trol resulted in the generation of fragmented monomers 
(Figure 4G; 3.0-4.0 kDa bands). A decrease in the oligo-
mer band intensity was observed with an increase in the 
incubation time with PK (Figure  4H). All the oligomers 
showed nearly complete digestion within 20  minutes but 
GM1Os showed the most susceptibility to PK with com-
plete digestion within 10 minutes (Figure 4H). These re-
sults indicate that all the oligomers show somewhat similar 
stability toward PK digestion. However, slightly increased 
susceptibility for GM1Os may suggest a less compact 
structural organization for GM1Os as compared to the 
other oligomers which parallel the thermal denaturation 
experiment observed (Figure 4F).
F I G U R E  3  AFM height and phase images for 1-2 µM samples of freshly isolated oligomers samples imaged on a mica grid: (A-B) 14LPOs, 
(E-F) 16LPOs, (I-J) GM1Os. Scale bars represent 50 nm. Statistical height and phase analysis of AFM images for (C-D) 14LPOs, (G-H) 16LPOs, 
and (K-L) GM1Os
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3.5 | Conformation-sensitive dyes and 
antibodies reveal subtle structural differences 
among oligomers relatable to cytotoxicity
The natural product curcumin has been known to bind am-
yloid aggregates.66-68 Recently, Condello and co-workers 
showed that curcumin discriminates between wild-type and 
mutant Aβ deposits derived from familial AD and CAA brain 
tissue based on the intensity and emission wavelength of the 
fluorescence spectrum.66 Similarly, other fluorescent dyes 
such as polythiophenes have been shown to display different 
fluorescent properties upon binding to the sample tissues from 
varying etiological subtypes of AD.17 We evaluated curcumin 
fluorescence in the presence of Aβ monomers, oligomers, and 
fibrils to explore if any differences in the spectroscopic prop-
erties could be discerned (Figure 5). The addition of curcumin 
(5 μM) to a solution of monomeric Aβ showed an emission 
spectrum centered at 560 nm (■; Figure 5A). All oligomers 
such as LFAOs, 14LPOs, 16LPOs, and GM1Os, as well as 
control fibrils, showed blue shifts to varying degrees, with 
GM1Os showing the maximal shift (Figure 5A,B). In addition, 
the oligomers showed variations in the intensity of florescence 
upon binding to the dye 8-anilino-1-naphthalenesulfonic acid 
(ANS), which is known to bind solvent-exposed hydrophobic 
surfaces (Figure 5C). LFAOs, 14LPOs, and 16LPOs showed 
identical increases in the intensity, while GM1Os showed 
nearly double the intensity compared to the rest of the oligom-
ers (Figure 5C). We rule out that the increase is due to the lipid 
associated with GM1Os as compared to the blank lipid sample 
(data not shown). However, the contributions of lipid-induced 
structural changes leading to the exposure of hydrophobic sur-
faces cannot be ruled out. 1D 1H NMR spectra of the amide re-
gion for the oligomers indicated significant differences in the 
spectra of GM1Os as compared to the others with many amide 
resonances shifted or unobserved (Figure 5D), suggesting dif-
ferent dynamics of conformational exchange and structure for 
the oligomers. Immunodetection by conformation-specific 
antibodies, A11 (oligomer-specific) and OC (fibril-specific) 
indicate that LFAOs, as previously known, and 14LPOs show 
OC-positivity (Figure 5E). While 16LPOs and GM1Os also 
F I G U R E  4  A-E, CD spectra of 1 µM 
GM1O, 14LPO, 16LPO, LFAO, and fibrils, 
respectively, before (black) and after 
(grey) their thermal denaturation (10-90°C) 
from β-sheet to α-helix in presence of 1% 
SDS. F, Normalized denaturation profiles 
obtained from CD spectra at 208 nm upon 
the addition of 1% SDS and increase in 
temperature from 10 to 90°C for: 14LPOs 
(●), 16LPOs (○), LFAOs (✰), GM1Os (□) 
and fibrils (ᐊ). The spectra were fit with a 
Boltzmann's sigmoidal function. G, Partially 
denaturing SDS-PAGE -immunoblots of Aβ 
oligomers upon digestion with proteinase-K 
(PK) enzyme initiated with 1:2500 enzyme: 
protein ratio and monitored temporally for 
10, 20, 30, and 40 minutes. C is the control 
reaction at 0 h without PK. H, Protein band 
intensities derived from (G) plotted as a 
function of time for GM1Os (□), LFAOs 
(✰), 16LPOs (○), and 14 LPOs (●)
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show OC-positive detection, they also showed a somewhat di-
minished A11-positive character (Figure 5E). To see whether 
the differences observed for GM1Os manifest in their cellular 
toxicities, the viability of SHSY5Y neuroblastoma cells upon 
treatment with the oligomers were investigated by XTT assay. 
After 40 hours of treatment, nearly 60% of the cells died due 
to GM1O exposure, while only ~40% were dead upon expo-
sure with other oligomers (Figure 5F). Together, the data sug-
gest that the biophysical differences between the oligomers 
correlate with their respective cellular toxicities.
3.6 | Lipid-derived Aβ oligomers 
show differential seeding resulting in 
morphologically different fibrils
Structural differences among oligomers often manifest in the 
morphology of their seeded fibrils. To see if the oligomers 
show differences in fibril morphologies generated upon seed-
ing monomers, reactions were initiated by seeding Aβ mono-
mer (25 μM) with 5 μM (20%) of 14LPOs (◊), 16LPOs (▽) 
or GM1Os (○) seeds individually. Reactions were buffered 
in 20 mM Tris (pH 8.0) with 50 mM NaCl and were main-
tained under quiescent conditions at 37°C. The aggregation 
reactions were deliberately initiated with high seed amounts 
(20%) and under quiescent conditions to minimize nucleated 
aggregation reaction among monomers and to maximize tem-
plated, seeded aggregation by the oligomers. The samples 
were centrifuged after 30 days of incubation at 37°C, and the 
sedimented pellets were washed with buffer and subjected to 
analysis by AFM. Samples for 14LPOs, 16LPOs, and GM1Os 
showed fairly smooth fibrils on the mica grid (Figure 6A,D,G, 
respectively). Detailed analysis of the morphologies, how-
ever, revealed that both 14LPO-seeded and 16LPO-seeded 
fibrils displayed periodic repeats of crests and troughs along 
the length of the fibril (Figure 6A,D; white arrows) with 3.0-
4.5  nm heights (Figure  6B,E; right panels). These heights 
are identical to those observed for individual oligomers 
(Figure 3), leading us to conjecture that the fibrils were com-
prised of individual oligomer units that give rise to “repeat 
morphology.” Identical morphology was observed previously 
for LFAO-seeded fibrils.9 The cross-sectional analysis per-
pendicular to the fibril axis (colored lines) showed heights of 
~4.0 and 6.0 nm for 14LPO-seeded and 16LPO-seeded fibrils, 
respectively (Figure 6D,G; right panels). This was consistent 
in many different fields in the mica grid (Figure 6J). In sharp 
contrast, GM1O-seeded fibrils did not show such a repeat 
morphology but showed a cross-sectional height of ~5  nm 
(Figure  6G,H,I,I). Together, these results indicate that both 
14LPOs and 16LPOs are able to generate fibrils of similar 
morphologies, GM1Os showed significant deviations both in 
temporal profiles and fibril morphology.
F I G U R E  5  A, Normalized fluorescence emission scans for curcumin (5 μM in 25% EtOH) binding to 5-10 uM Aβ monomers (■), LFAOs 
(✰), 14LPOs (●), 16LPOs (○), GM1Os (▼), or fibrils (◁). B, Shifts in the emission maximum from that of the monomers (ΔλEmmax ) of the 
samples in (A). C, Blank corrected intensities of λEm
max for ANS dye (100 μM in 20 mM Tris pH 8.0) binding to 3 μM oligomers. D, 1D 1H NMR 
spectra of the amide region for the oligomers that show backbone structural differences and similarities between the oligomers. E, Dot blots for 
the oligomers and monomers using sequence-specific Ab5 monoclonal antibody and conformation-specific monoclonal antibodies A11 (oligomer-
specific) and OC (fibril-specific). F, Viability for SHSY5Y neuroblastoma cells measured by XTT assay upon incubating with oligomers expressed 
in terms of % of dead cells. n = 3 independent cell cultures on isolated oligomers; *, ** and *** P < .05 based on one-way ANOVA analysis
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3.7 | Aβ oligomers injection into Tg CRND8 
mice induce amyloid pathology and vascular 
amyloid deposition
Based on the aforementioned biophysical data and the previ-
ously observed effects of LFAOs on amyloid accumulation 
and CAA formation in CRND8 mice,9 we set to test whether 
the introduction of the oligomers to the neonatal brains of 
AD transgenic mice will result in the extended propagation 
of oligomers and fibril deposition. Thus, 4 μL of 10  μM 
preparations of 14LPOs, 16LPOs, and GM1Os along with 
Aβ42 monomers and LFAOs as controls were bilaterally 
injected into the cerebral ventricles of three litters of new-
born Tg CRND8 mice. After three months, the mice were 
euthanized and brains were extracted. One hemibrain was 
frozen for further biochemical analysis, while the other 
was fixed in 4% paraformaldehyde, paraffin-embedded, 
and processed for immunostaining. Upon analysis, the con-
trol mice injected with Aβ42 monomer exhibited a sparse 
number of small amyloid deposits both in the cortex and 
hippocampus, whereas the injection of LFAO resulted in 
increased levels of Aβ40 and Aβ42 in both SDS and for-
mic acid (FA) fractions similarly to what was shown in 
(Figure  7A-F).9 LFAO administration also expedited the 
accumulation of amyloid in the CAA as previously ob-
served (Figure  7G,I).9 Interestingly, injection of 14LPOs 
did not alter Aβ levels in the SDS fraction significantly but 
did so in the FA-soluble fractions, suggesting that the oli-
gomers induced insoluble fibrils deposition. It also did not 
affect the accumulation of CAA in the vasculature. In con-
trast, 16LPO injection resulted in increased levels of Aβ42 
in SDS-soluble fraction as well as increased Aβ40 and 
Aβ42 in FA-soluble fraction. The oligomers also induced 
an increased burden of CAA-laden vessels (Figure 7G,I). 
GM1O administration to neonatal CRND8 mice also re-
sulted in increased Aβ levels in both SDS and FA fractions, 
similar to LFAOs and 16LPOs (Figure 7C-F). Overall, we 
demonstrate a twofold increase in Aβ40 and Aβ42 in SDS-
soluble and SDS-insoluble FA-soluble fractions of GM1Os 
compared to the monomer control. Furthermore, GM1Os 
induced widespread CAA in cerebral vasculature and over-
all Aβ burden (Figure 7G-I). However, injection of all the 
oligomers samples at lower concentrations (1 μM) did not 
result in significant amyloid accumulation in the brains 
(Figure S5). Together, these suggest that LFAOs, 16LPOs, 
and GM1Os propagate and induce amyloid deposition in 
parenchyma and cerebral vasculature with GM1Os and 
16LPOs showing the maximal effect.
4 |  DISCUSSION
Monomeric Aβ peptides self-associate to form large fibril-
lar aggregates that deposit as insoluble, protease-resistant 
plaques in AD. NMR structures of fibrils propagated in vitro 
using brain-derived amyloid seeds as templates have revealed 
structural differences between morphologically distinguisha-
ble aggregates.15,69 Similarly, conformation sensitive fluores-
cent dyes have also identified the presence of heterogeneous 
F I G U R E  6  A, D, G, AFM images of Aβ fibrils generated from 
obtained from aggregation kinetics of Aβ monomers (25 μM) seeded 
with 5 μM of 14LPOs, 16LPOs or GM1Os in 20 mM Tris, pH 8.0, 
with 50 mM NaCl and 50 μM ThT at 37°C under quiescent conditions 
after 30 days of incubation. Scale bar is 200 nm. Statistical height 
analysis along cross-sectional and longitudinal axes on the AFM 
images indicated by colored lines and arrows, respectively, for; (B-
C) 14LPO-seeded, (E-F) 16LPO-seeded, and (H-I) GM1O-seeded 
fibrils. J, Cross-sectional height analysis of the fibrils visualized on at 
least twelve different fields from at least three independent data sets. 
The data obtained from these also show no “repeat morphology” for 
GM1Os, unlike other two oligomers
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aggregate conformations in the brain that correlate with di-
verse phenotypes in AD such as those corresponding to late 
or early onset, rapidly progressing or anatomical region of 
deposition.17,66 Top-down discoveries such as these have un-
equivocally established that differences in aggregate struc-
tures may lead to different phenotypes in the brain. Since 
low molecular weight soluble oligomers are known to be the 
primary toxic species in the aggregation pathway, a question 
then arises as to whether conformationally distinct oligom-
ers are capable of faithful propagation of their structures to-
ward distinguishable fibril morphologies, and if so, whether 
such a propagation will manifest in phenotypic differences in 
the AD brains. Here, we approached to answer this question 
bottom-up by generating distinct oligomer sub-types and cor-
relating their biophysical properties with observable effects 
in transgenic AD mice brains. We have earlier demonstrated 
that LFAOs generated in the presence of fatty acid propa-
gate their structure toward distinct fibrils on the mesoscopic 
scale and selectively induce CAA in a transgenic AD mouse 
model.9 Here, we used micelle forming phospholipids and a 
sphingolipid to generate stable oligomers, characterize their 
biophysical differences and similarities, and correlate them 
with the phenotypes induce in C8ND8 mice.
The results obtained here bring forth several salient infer-
ences. First, the micellar anionic phospholipids promote the 
formation of disperse ~60-120 kDa (5-8S) Aβ42 oligomers, 
which corresponds to a 12-26mer species. Despite being 
somewhat heterogenous, this size is comparable to the ear-
lier characterized LFAOs,42 which suggests that the carbon 
chain length variations (12, 14, or 16 carbon acyl chains) do 
not seem to have a noticeable effect on the size of the oligo-
mer generated. However, LFAOs were generated with fatty 
acid near its CMC and not above, which implicates the sig-
nificance of micelles in the case of phospholipids. Second, 
micelles of the neutral sphingolipid GM1 ganglioside induce 
the formation of slightly smaller and more discrete ~40 and 
80 kDa (3 and 6.5 S) species corresponding to 9 and 18mers. 
The slightly different sizes obtained from GM1 lipids could 
be attributed to neutral charge, longer acyl chains (18,20), 
carbohydrate moiety, or all three.
Among the isolated oligomers reported here, GM1Os 
stand out as a distinct outlier on the observed biophysical and 
biochemical attributes. GM1Os do share similarities on par-
allel β-sheet secondary structure and a ring-like morphology 
as well as the size range. However, they show stark biophysi-
cal differences too (Figure 8). For example, the amide region 
of the 1H NMR spectra indicates structural dynamics and 
assembly differences in GM1Os which is corroborated by 
the greater degree of exposed hydrophobic surfaces by ANS 
binding and decreased enzymatic and thermal stabilities. 
Similarly, GM1Os and 16LPOs show reactivity toward both 
conformation-specific A11 and OC antibodies unlike the 
F I G U R E  7  Oligomers induce widespread amyloid deposition and CAA in TgCRND8 mice. Newborn CRND8 mice were injected with 
4 μL aliquots of Aβ42 monomers, LFAOs, 14LPOs, 16LPOs, and GM1Os (10 μM) in the cerebral ventricles. Three months later, brains were 
extracted and one hemibrain was frozen, while another was fixed and stained with anti-pan- Aβ mAb5 Biotin antibody. A-F, Biochemical analyses 
of sequentially extracted Aβ42 and Aβ40 levels by end-specific sandwich ELISA show significantly increased SDS soluble and FA soluble 
Aβ levels in LFAOs, 16LPOs, and GM1Os injected mice compared to monomer injected mice. Data represent mean ± sem. n = 6-10 mice 
per group. N = 6-10, *P < .05, **P < .01, ***P < .001, ****P < .0001, one-way ANOVA). G, Amyloid staining of plaques and CAA in the 
representative paraffin sections is shown in the cortex and meningeal vessels of injected mice. Scale Bar, 500 μm (cortex), 100 μm (hippocampus). 
H, Quantification of Aβ positive immunostaining shows significantly increased amyloid plaque burden (immunostained with anti-pan-Aβ 
mAb5Biotin). Data represent mean ± SEM. n = 6-10/group. **P < .01, ***P < .001, one-way ANOVA. I, Quantification of CAA. Aβ positive 
blood vessels in the meninges and throughout the brain tissue were evaluated in a blind manner and given a qualitative score from 0 to 3. Vessels 
with scores 0, 1, 2 or 3 were counted. Data represent mean ± sem. n = 6-10 per group. ***P < .001, one-way ANOVA
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other two which show only OC specificity. Such differences 
are also manifested in their ability to propagate morpholog-
ically distinct fibrils; 14LPOs and 16LPOs but not GM1Os, 
generate fibrils containing a “repeat” morphological feature 
similar to LFAOs.9 These observations are summarized in 
Figure 8 that show biophysical differences among the oligo-
mers investigated in this study. Such biophysical differences 
also have direct and correlatable manifestations in vivo. Cell 
viability assays indicate that GM1Os to be the most po-
tent in cellular toxicity as compared to the other oligomers. 
Similarly, in CRND8 mice too, GM1Os showed profound 
effects on both the induction of total Aβ burden and CAA. 
Surprisingly, despite significant biophysical differences, 
GM1Os, 16LPOs, and LFAOs show high but comparable ef-
fects on amyloid deposition in CRND8 mice.
There can be several features within the lipid that are attrib-
utable to the generation of Aβ oligomers and their observed 
properties. It is possible that the development of pathology 
following Aβ seeding depends tightly on the size and solubil-
ity of initial seeds and not on their biochemical properties.70 
The oligomers compared here have somewhat similar sizes; 
however, the lipid characteristics are different; in comparison 
to the anionic LPGs used in this study, GM1 gangliosides dif-
fer in acyl chain lengths, charge, and head groups, which may 
confer GM1Os their distinctive properties. A recent report on 
the interactions of Aβ with synthetic glycopolymer mimics 
revealed the selective induction of Aβ oligomers by glyco-
polymers containing purely glucose pendant groups,71 which 
implicates that sugar distribution in GM1 ganglioside is im-
portant for oligomer generation. In addition, ~20% of isolated 
GM1Os contain GM1 lipid which could also have a role to 
play in their behavior in mice. The increased hydrophobic 
character is consistent with the lipid-bound oligomer form, 
which may manifest in its lipid solubility, bioavailability, and 
seeding in vivo. It is also rational to conjecture that a stable 
oligomer strain is more likely to be present in a lipid-bound 
form than in a purely homogenous form. Such a contention is 
also consistent with earlier reports on Aβ oligomers isolated 
from postmortem AD brains that were associated with GM1 
gangliosides.28,29 GM1 gangliosides are important compo-
nents of lipid rafts that have been known to play important 
roles in AD.30 Therefore, it is comprehensible that lipid asso-
ciation to the isolated GM1Os could play a role in their bio-
physical and biochemical distinctions. The slightly decreased 
PK stability of GM1Os seems to be counter-intuitive to their 
effect on mice brains. It is possible that the lipid association 
is partly responsible for the exposure of polypeptide back-
bone for increased enzymatic cleavage, but the lipid associa-
tion could also increase the lipophilicity of the oligomers to 
effectively propagate in parenchyma, meninges, and cerebro-
spinal fluid.
The results presented here demonstrate that oligomers 
with distinct properties can be tuned by changing the phys-
iochemical properties of lipids and support the hypothesis 
that varying lipid environments could play important roles in 
the generation of conformeric oligomer strains.72 Along the 
same lines, these also lead to the conjecture that while oligo-
mers may have different structures to present themselves as 
conformational “strains,” they may also possess common 
features and traits such as those observed for oligomers de-
rived from anionic lipids. Despite the numerous challenges 
these oligomers present, understanding the atomic details of 
their structures would be essential to further decipher their 
mechanisms and functions. Furthermore, understanding the 
physiological relevance of lipid-derived oligomers by inves-
tigating their in vivo behavior in detail would be essential. In 
addition, the ability of these oligomers to propagate cell-to-
cell transmissions needs to be assessed to assess their pro-
pensity to truly behave like infectious prions or “strains”.73-76 
Although the in vitro oligomers presented here clearly show 
pathology in mice, ascertaining whether and how they rep-
resent those present in human brains is important. Recent 
reports on the structure of in vitro fibrils generated by the 
propagation of brain-derived seeds have made a significant 
F I G U R E  8  Summary of results indicating the differences and similarities between the oligomers. The grey boxes indicate the salient 
differences in GM1Os as compared to the others; “=” and “≠”, respectively, indicate similar or dissimilar to other oligomers
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leap in this regard. However, it is non-trivial to investigate 
oligomers derived from brain samples due to their transiency, 
heterogeneity, and difficulty to isolate. Despite these issues, 
characterizing them continues to remain as a major focus in 
ours and other laboratories. Nevertheless, the data presented 
here as such showcase the generation of biophysically dis-
tinct oligomers by modulating the lipid characteristics, and 
one that correlates to their biochemical proprieties in vivo. 
Establishing such structure-phenotype correlations are im-
perative to decipher the mechanisms by which oligomers im-
part strain-like properties.
ACKNOWLEDGMENTS
The authors would like to thank the following agen-
cies for financial support: National Institute of Aging 
(1R56AG062292-01), National Institute of General Medical 
Sciences (R01GM120634), and the National Science 
Foundation (NSF CBET 1802793) to VR, NSF Graduate 
Research Fellowship Program (NSF 1445151) to DND and 
NSF NRT (NRT 1449999) to KAS. The authors also thank 
the National Center for Research Resources (5P20RR01647-
11) and the National Institute of General Medical Sciences 
(8 P20 GM103476-11) from the National Institutes of Health 
for funding through INBRE for the use of their core facili-
ties. The authors also thank Dr Claudius Mundoma and FSU 
Physical Biochemistry facility for their generous help in col-
lecting AUC data.
CONFLICT OF INTEREST
The authors declare no conflicts of interest.
AUTHOR CONTRIBUTIONS
V. Rangachari conceptualized the paper, J. Saha and D.N. 
Dean performed biophysical experiments, S. Dhakal per-
formed cellular toxicity assays, K.A. Stockmal and S.E. 
Morgan performed M.F. Adamo experiments, K.D. Dillon, 
M.F. Adamo, and Y. Levites performed transgenic mice 
experiments. All authors contributed to manuscript writing 
but were mainly performed by J. Saha, D.N. Dean, and V. 
Rangachari. All authors have given approval to the final ver-
sion of the manuscript.
REFERENCES
 1. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. 
Physiol. Rev. 2001;81:741-766.
 2. Westerman MA, Cooper-Blacketer D, Mariash A, et al. The rela-
tionship between Abeta and memory in the Tg2576 mouse model 
of Alzheimer's disease. J Neurosci. 2002;22:1858-1867.
 3. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. 
Intraneuronal Abeta causes the onset of early Alzheimer's disease-re-
lated cognitive deficits in transgenic mice. Neuron. 2005;45:675-688.
 4. Gong Y, Chang L, Viola KL, et al. Alzheimer's disease-affected 
brain: presence of oligomeric Aβ ligands (ADDLs) suggests a 
molecular basis for reversible memory loss. Proc Natl Acad Sci. 
2003;100:10417-10422.
 5. Haass C, Selkoe DJ. Soluble protein oligomers in neurodegenera-
tion: lessons from the Alzheimer's amyloid β-peptide. Nat Rev Mol 
Cell Biol. 2007;8:101-112.
 6. Jongbloed W, Bruggink KA, Kester MI, et al. Amyloid-beta 
oligomers relate to cognitive decline in Alzheimer's disease. J 
Alzheimer's Dis. 2015;45:35-43.
 7. McLean CA, Cherny RA, Fraser FW, et al. Soluble pool of Abeta 
amyloid as a determinant of severity of neurodegeneration in 
Alzheimer's disease. Ann Neurol. 1999;46:860-866.
 8. Lue LF, Kuo YM, Roher AE, et al. Soluble amyloid beta peptide 
concentration as a predictor of synaptic change in Alzheimer's dis-
ease. Am J Pathol. 1999;155:853-862.
 9. Dean DN, Das PK, Rana P, et al. Strain-specific fibril propagation 
by an Aβ dodecamer. Sci Rep. 2017;7:40787.
 10. Petkova AT, Leapman RD, Guo Z, Yau WM, Mattson MP, Tycko 
R. Self-propagating, molecular-level polymorphism in Alzheimer's 
beta-amyloid fibrils. Science. 2005;307:262-265.
 11. Kodali R, Williams AD, Chemuru S, Wetzel R. Aβ(1–40) forms 
five distinct amyloid structures whose β-sheet contents and fibril 
stabilities are correlated. J Mol Biol. 2010;401:503-517.
 12. Watanabe-Nakayama T, Ono K, Itami M, Takahashi R, Teplow 
DB, Yamada M. High-speed atomic force microscopy reveals 
structural dynamics of amyloid beta1-42 aggregates. Proc Natl 
Acad Sci USA. 2016;113:5835-5840.
 13. Walker LC. Proteopathic strains and the heterogeneity of neurode-
generative diseases. Annu Rev Genet. 2016;50:329-346.
 14. Yates EA, Legleiter J. Preparation protocols of abeta(1–40) pro-
mote the formation of polymorphic aggregates and altered interac-
tions with lipid bilayers. Biochemistry. 2014;53:7038-7050.
 15. Lu JX, Qiang W, Yau WM, Schwieters CD, Meredith SC, Tycko R. 
Molecular structure of beta-amyloid fibrils in Alzheimer's disease 
brain tissue. Cell. 2013;154:1257-1268.
 16. Cohen ML, Kim C, Haldiman T, et al. Rapidly progressive 
Alzheimer's disease features distinct structures of amyloid-beta. 
Brain. 2015;138:1009-1022.
 17. Rasmussen J, Mahler J, Beschorner N, et al. Amyloid polymor-
phisms constitute distinct clouds of conformational variants in dif-
ferent etiological subtypes of Alzheimer's disease. Proc Natl Acad 
Sci USA. 2017;114:13018-13023.
 18. Condello C, Lemmin T, Stöhr J, et al. Structural heterogeneity and 
intersubject variability of Aβ in familial and sporadic Alzheimer’s 
disease. Proc Natl Acad Sci. 2018;115:E782-E791.
 19. Qiang W, Yau W-M, Lu J-X, Collinge J, Tycko R. Structural vari-
ation in amyloid-β fibrils from Alzheimer's disease clinical sub-
types. Nature. 2017;541:217-221.
 20. Planchard MS, Samel MA, Kumar A, Rangachari V. The natural 
product betulinic acid rapidly promotes amyloid-β fibril forma-
tion at the expense of soluble oligomers. ACS Chem Neurosci. 
2012;3:900-908.
 21. Arosio P, Knowles TP, Linse S. On the lag phase in amyloid fibril 
formation. Phys Chem Chem Phys. 2015;17:7606-7618.
 22. Kumar A, Bullard RL, Patel P, et al. Non-esterified fatty acids 
generate distinct low-molecular weight amyloid-β (Aβ42) oligo-
mers along pathway different from fibril formation. PLoS ONE. 
2011;6:e18759.
 23. Colin J, Gregory-Pauron L, Lanhers MC, et al. Membrane raft do-
mains and remodeling in aging brain. Biochimie. 2016;130:178-187.
   | 17 of 18 SAHA et Al.
 24. Naudi A, Cabre R, Jove M, et al. Lipidomics of human brain 
aging and Alzheimer's disease pathology. Int Rev Neurobiol. 
2015;122:133-189.
 25. Noel A, Ingrand S, Barrier L. Ganglioside and related-sphingo-
lipid profiles are altered in a cellular model of Alzheimer's disease. 
Biochimie. 2017;137:158-164.
 26. Kiskis J, Fink H, Nyberg L, Thyr J, Li JY, Enejder A. Plaque-
associated lipids in Alzheimer's diseased brain tissue visualized by 
nonlinear microscopy. Sci Rep. 2015;5:13489.
 27. Morgado I, Garvey M. Lipids in amyloid-beta processing, aggrega-
tion, and toxicity. Adv Exp Med Biol. 2015;855:67-94.
 28. Yanagisawa K, Odaka A, Suzuki N, Ihara Y. GM1 ganglio-
side-bound amyloid beta-protein (A beta): a possible form of pre-
amyloid in Alzheimer's disease. Nat Med. 1995;1:1062-1066.
 29. Yanagisawa K, Ihara Y. GM1 ganglioside-bound amyloid be-
ta-protein in Alzheimer's disease brain. Neurobiol Aging. 
1998;19:S65-67.
 30. Tettamanti G, Anastasia L. Chemistry, tissue and cellular distribu-
tion, and developmental profiles of neural sphingolipids. In: Lajtha 
A, Tettamanti G, Goracci G, eds. Handbook of Neurochemistry and 
Molecular Neurobiology: Neural Lipids. Boston, MA: Springer; 
2010:99-171.
 31. Choo-Smith LP, Garzon-Rodriguez W, Glabe CG, Surewicz WK. 
Acceleration of amyloid fibril formation by specific binding of 
Abeta-(1–40) peptide to ganglioside-containing membrane vesi-
cles. J Biol Chem. 1997;272:22987-22990.
 32. Ariga T, Kobayashi K, Hasegawa A, Kiso M, Ishida H, Miyatake 
T. Characterization of high-affinity binding between gan-
gliosides and amyloid beta-protein. Arch Biochem Biophys. 
2001;388:225-230.
 33. Matsuzaki K, Horikiri C. Interactions of amyloid beta-peptide 
(1–40) with ganglioside-containing membranes. Biochemistry. 
1999;38:4137-4142.
 34. Kakio A, Nishimoto S, Yanagisawa K, Kozutsumi Y, Matsuzaki 
K. Interactions of amyloid beta-protein with various gangliosides 
in raft-like membranes: importance of GM1 ganglioside-bound 
form as an endogenous seed for Alzheimer amyloid. Biochemistry. 
2002;41:7385-7390.
 35. Kakio A, Nishimoto SI, Yanagisawa K, Kozutsumi Y, Matsuzaki 
K. Cholesterol-dependent formation of GM1 ganglioside-bound 
amyloid beta-protein, an endogenous seed for Alzheimer amyloid. 
J Biol Chem. 2001;276:24985-24990.
 36. Choo-Smith LP, Surewicz WK. The interaction between Alzheimer 
amyloid beta(1–40) peptide and ganglioside GM1-containing 
membranes. FEBS Lett. 1997;402:95-98.
 37. Terzi E, Holzemann G, Seelig J. Self-association of beta-amyloid 
peptide (1–40) in solution and binding to lipid membranes. J Mol 
Biol. 1995;252:633-642.
 38. Terzi E, Holzemann G, Seelig J. Interaction of Alzheimer be-
ta-amyloid peptide(1–40) with lipid membranes. Biochemistry. 
1997;36:14845-14852.
 39. Bokvist M, Lindström F, Watts A, Gröbner G. Two types of 
Alzheimer's β-amyloid (1–40) peptide membrane interactions: ag-
gregation preventing transmembrane anchoring versus accelerated 
surface fibril formation. J Mol Biol. 2004;335:1039-1049.
 40. Rangachari V, Moore BD, Reed DK, et al. Amyloid-beta(1–42) 
rapidly forms protofibrils and oligomers by distinct pathways 
in low concentrations of sodium dodecylsulfate. Biochemistry. 
2007;46:12451-12462.
 41. Barghorn S, Nimmrich V, Striebinger A, et al. Globular amyloid 
beta-peptide oligomer - a homogenous and stable neuropatho-
logical protein in Alzheimer's disease. J Neurochem. 2005;95: 
834-847.
 42. Kumar A, Paslay LC, Lyons D, Morgan SE, Correia JJ, Rangachari 
V. Specific soluble oligomers of amyloid-β peptide undergo rep-
lication and form non-fibrillar aggregates in interfacial environ-
ments. J Biol Chem. 2012;287:21253-21264.
 43. Kumar A, Pate KM, Moss MA, Dean DN, Rangachari V. Self-
propagative replication of abeta oligomers suggests potential trans-
missibility in Alzheimer disease. PLoS ONE. 2014;9:e111492.
 44. Dean DN, Pate KM, Moss MA, Rangachari V. Conformational dy-
namics of specific Aβ oligomers govern their ability to replicate 
and induce neuronal apoptosis. Biochemistry. 2016;55:2238-2250.
 45. Dean DN, Rana P, Campbell RP, Ghosh P, Rangachari V. 
Propagation of an Aβ dodecamer strain involves a three-step mech-
anism and a key intermediate. Biophys J. 2018;114:539-549.
 46. Xi W, Dean DN, Stockmal KA, Morgan SE, Hansmann UH, 
Rangachari V. Large fatty acid-derived A β 42 oligomers form 
ring-like assemblies. J Chem Phys. 2019;150:075101.
 47. Chemes LB, Alonso LG, Noval MG, de Prat Gay G.Circular 
Dichroism Techniques for the Analysis of Intrinsically Disordered 
Proteins and Domains In: Uversky V., Dunker A. (eds) Methods 
in Molecular Biology (Methods and Protocols)895Humana Press: 
Totowa, NJ; 2012 https://doi.org/10.1007/978-1-61779 -927-3_22.
 48. Kaspersen JD, Søndergaard A, Madsen DJ, Otzen DE, Pedersen 
JS. Refolding of SDS-unfolded proteins by nonionic surfactants. 
Biophys J. 2017;112:1609-1620.
 49. Hou H, He H, Wang Y. Effects of SDS on the activity and confor-
mation of protein tyrosine phosphatase from thermus thermophilus 
HB27. Sci Rep. 2020;10:1-8.
 50. Van Holde KE, Weischet WO. Boundary analysis of sedimenta-
tion-velocity experiments with monodisperse and paucidisperse 
solutes. Biopolymers. 1978;17:1387-1403.
 51. Santacruz K, Lewis J, Spires T, et al. Tau suppression in a neu-
rodegenerative mouse model improves memory function. Science. 
2005;309:476-481.
 52. Sacino AN, Brooks M, McGarvey NH, et al. Induction of CNS 
α-synuclein pathology by fibrillar and non-amyloidogenic recom-
binant α-synuclein. Acta Neuropathol Commun. 2013;1:38.
 53. Howard AJ, Williams HM. The prevalence of antibiotic resistance 
in Haemophilus influenzae in Ireland. J Antimicrob Chemother. 
1989;24:963-971.
 54. Stafford RE, Fanni T, Dennis EA. Interfacial properties and crit-
ical micelle concentration of lysophospholipids. Biochemistry. 
1989;28:5113-5120.
 55. Ikeda K, Shimizu T, Taguchi R. Targeted analysis of ganglioside 
and sulfatide molecular species by LC/ESI-MS/MS with the-
oretically expanded multiple reaction monitoring. J Lipid Res. 
2008;49:2678-2689.
 56. Ju DD, Lai CC, Her GR. Analysis of gangliosides by capillary zone 
electrophoresis and capillary zone electrophoresis-electrospray 
mass spectrometry. J Chromatogr A. 1997;779:195-203.
 57. Couto D, Melo T, Maciel E, et al. New insights on non-enzymatic 
oxidation of ganglioside GM1 using mass spectrometry. J Am Soc 
Mass Spectrom. 2016;27:1965-1978.
 58. Kong J, Yu S. Fourier transform infrared spectroscopic analy-
sis of protein secondary structures. Acta Biochim Biophys Sin. 
2007;39:549-559.
18 of 18 |   SAHA et Al.
 59. Gu L, Liu C, Stroud JC, Ngo S, Jiang L, Guo Z. Antiparallel tri-
ple-strand architecture for prefibrillar Abeta42 oligomers. J Biol 
Chem. 2014;289:27300-27313.
 60. Huang D, Zimmerman MI, Martin PK, Nix AJ, Rosenberry 
TL, Paravastu AK. Antiparallel beta-sheet structure within 
the C-terminal region of 42-residue Alzheimer's amyloid-beta 
peptides when they form 150-kDa oligomers. J Mol Biol. 
2015;427:2319-2328.
 61. Cerf E, Sarroukh R, Tamamizu-Kato S, et al. Antiparallel be-
ta-sheet: a signature structure of the oligomeric amyloid beta-pep-
tide. Biochem J. 2009;421:415-423.
 62. G Creasey R, T Gibson C, H Voelcker N. Characterization of fi-
ber-forming peptides and proteins by means of atomic force mi-
croscopy. Curr Protein Pept Sci. 2012;13:232-257.
 63. Downey MA, Giammona MJ, Lang CA, Buratto SK, Singh A, 
Bowers MT. Inhibiting and remodeling toxic amyloid-beta oligomer 
formation using a computationally designed drug molecule that tar-
gets Alzheimer’s disease. J Am Soc Mass Spectrom. 2018;30:85-93.
 64. Pountney DL, Lowe R, Quilty M, Vickers JC, Voelcker NH, Gai 
WP. Annular α-synuclein species from purified multiple system 
atrophy inclusions. J Neurochem. 2004;90:502-512.
 65. Andersen NH, Liu Z, Prickett KS. Efforts toward deriving the 
CD spectrum of a 310 helix in aqueous medium. FEBS Lett. 
1996;399:47-52.
 66. Condello C, Lemmin T, Stohr J, et al. Structural heterogene-
ity and intersubject variability of Abeta in familial and sporadic 
Alzheimer's disease. Proc Natl Acad Sci. 2018;115:E782-E791.
 67. Yanagisawa D, Taguchi H, Yamamoto A, Shirai N, Hirao K, 
Tooyama I. Curcuminoid binds to amyloid-β 1–42 oligomer and 
fibril. J Alzheimers Dis. 2011;24:33-42.
 68. Yang F, Lim GP, Begum AN, et al. Curcumin inhibits formation of 
amyloid β oligomers and fibrils, binds plaques, and reduces amy-
loid in vivo. J Biol Chem. 2005;280:5892-5901.
 69. Qiang W, Yau WM, Lu JX, Collinge J, Tycko R. Structural varia-
tion in amyloid-beta fibrils from Alzheimer's disease clinical sub-
types. Nature. 2017;541:217-221.
 70. Xu G, Fromholt SE, Chakrabarty P, et al. Diversity in Aβ deposit 
morphology and secondary proteome insolubility across mod-
els of Alzheimer-type amyloidosis. Acta Neuropathol Commun. 
2020;8:1-17.
 71. Das PK, Dean DN. Aqueous RAFT synthesis of glycopolymers for 
determination of saccharide structure and concentration effects on 
amyloid beta aggregation. Biomacromol. 2017;18:3359-3366.
 72. Watts JC, Condello C, Stöhr J, et al. Serial propagation of distinct 
strains of Aβ prions from Alzheimer’s disease patients. Proc Natl 
Acad Sci. 2014;111:10323-10328.
 73. Buyukmihci N, Goehring-Harmon F, Marsh RF. Neural pathogen-
esis of experimental scrapie after intraocular inoculation of ham-
sters. Exp Neurol. 1983;81:396-406.
 74. Kimberlin RH, Walker CA. Pathogenesis of scrapie (strain 263K) 
in hamsters infected intracerebrally, intraperitoneally or intraocu-
larly. J Gen Virol. 1986;67(Pt 2):255-263.
 75. Liberski PP, Hainfellner JA, Sikorska B, Budka H. Prion pro-
tein (PrP) deposits in the tectum of experimental Gerstmann-
Straussler-Scheinker disease following intraocular inoculation. 
Folia Neuropathol. 2012;50:85-88.
 76. Rasmussen J, Jucker M, Walker LC. Abeta seeds and prions: how 
close the fit? Prion. 2017;1-11.
SUPPORTING INFORMATION
Additional Supporting Information may be found online in 
the Supporting Information section.
How to cite this article: Saha J, Dean DN, Dhakal S, 
et al. Biophysical characteristics of lipid-induced Aβ 
oligomers correlate to distinctive phenotypes in 
transgenic mice. The FASEB Journal. 2021;35:e21318. 
https://doi.org/10.1096/fj.20200 2025RR
